Joan edukira
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aurreratua
  • Genetic landscape and clinical...
  • Erreferentzia bihurtu
  • SMS
  • Bidali
  • Imprimir
  • Erregistroa esportatu
    • Nora RefWorks
    • Nora EndNoteWeb
    • Nora EndNote
  • Permanent link
Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma

Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma

Xehetasun bibliografikoak
Egile Nagusiak: Dingtao Hu, Yichuan Wang, Xu Shen, Tiantian Mao, Xijun Liang, Tengjiao Wang, Weifeng Shen, Yugang Zhuang, Jin Ding
Formatua: Artikulua
Hizkuntza:English
Argitaratua: KeAi Communications Co., Ltd. 2024-03-01
Saila:Genes and Diseases
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S235230422300123X
  • Aleari buruzko argibideak
  • Deskribapena
  • Antzeko izenburuak
  • MARC erregistroa
Deskribapena
ISSN:2352-3042

Antzeko izenburuak

  • Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
    nork: Xinqiang Li, et al.
    Argitaratua: (2022-11-01)
  • Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
    nork: Lei Ding, et al.
    Argitaratua: (2022-09-01)
  • Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
    nork: Xiaolong Tang, et al.
    Argitaratua: (2023-01-01)
  • DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma
    nork: Tianxing Li, et al.
    Argitaratua: (2024-09-01)
  • Synergistic SDT/cuproptosis therapy for liver hepatocellular carcinoma: enhanced antitumor efficacy and specific mechanisms
    nork: Yucao Sun, et al.
    Argitaratua: (2024-12-01)

Bilaketa aukerak

  • Bilaketaren historia
  • Bilaketa aurreratua

Gehiago bilatu

  • Katalogoa arakatu
  • Bilaketa alfabetikoki
  • Esploratu kanalak
  • Erreserba egin ezazu
  • Berriak liburutegietan

Laguntza behar al duzu?

  • Bilaketa egiteko aholkuak
  • Galdetu liburuzainari
  • FAQ